Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta and Cisplatin in Malignant Pleural Mesothelioma
NCT00895648Phase 2Terminated
- Sponsor
- University Health Network
- Start
- Jan 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in malignant pleural mesothelioma (MPM), sponsored by University Health Network. Started Jan 2009; status: terminated.
02
Drugs
pemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00895648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895648.